Renal Cancer - Results from #660

Long-Term Follow-Up in Patients Undergoing Renal Mass Biopsy: Seeding is not Anecdotal. November 22, 2023

Perceptions of DNA Sequencing Among Patients with Cancer from Diverse Ancestries - Expert Commentary November 21, 2023

Robotic-assisted cytoreductive partial nephrectomy for metastatic sarcomatoid renal cell carcinoma following dramatic response to combination immunotherapy in a young female. November 21, 2023

Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma Patients. November 21, 2023

Biomarkers in renal cell carcinoma and their targeted therapies: a review. November 20, 2023

Benefits of Routine Screening for Renal Cell Carcinoma of Native Kidney in Renal Transplant Recipients. November 20, 2023

Geriatric nutritional risk index as a prognostic marker of first-line immune checkpoint inhibitor combination therapy in patients with renal cell carcinoma: a retrospective multi-center study. November 17, 2023

Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas. November 17, 2023

An Observational Case-Control Study on Parental Age and Childhood Renal Tumors. November 16, 2023

Diagnostic Value Analysis of Multi-Slice Helical Computed Tomography Reconstruction Parameters Combined with 3.0 T Magnetic Resonance in Clear Cell Renal Cell Carcinoma. November 16, 2023

Single-Probe Percutaneous Cryoablation with Liquid Nitrogen for the Treatment of T1a Renal Tumors. November 15, 2023

Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma. November 15, 2023

Could a Risk-adapted Approach Support Shared Decision-making Regarding Eligibility for Adjuvant Pembrolizumab for Patients with Clear Cell Renal Cell Carcinoma at High Risk of Recurrence? A Multicentre Cohort Study. November 14, 2023

Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma. November 14, 2023

A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer. November 13, 2023

A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell Carcinoma. November 13, 2023

Exelixis Announces Encouraging Results from Expansion Cohort of Phase 1b STELLAR-001 Trial Evaluating Zanzalintinib in Patients with Advanced Kidney Cancer at IKCS 2023 November 10, 2023

Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9). November 9, 2023

Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature. November 9, 2023

Real-World Results of Cabozantinib Given as Alternative Schedule in Metastatic Renal Cell Carcinoma. November 9, 2023

Page 34 of 457